Corporate Finance M&A Deals Old Articles
Elan – from buyer to target?
Elan Corporation PLC – Market Cap (as of 01/03/13) : $6.7bn Royalty Management, LLC On Monday, 25 February 2013, Royalty Pharma, the American private equity firm investing in acquiring drug royalties, made an indicative offer to acquire all the outstanding shares of Elan Corporation, the Irish biotech company listed in Read more…